

"The world's first Innovation CRO accelerating MedTech from concept to commercialisation"
Veranex is the world's first Innovation Contract Research Organisation (iCRO), uniting product design, engineering, preclinical research, clinical trials, regulatory affairs, and market access under one roof. Traditional CROs fragment device development with multiple hand-offs. Veranex removes barriers by connecting cross-disciplinary experts, delivering proven speed and next-generation devices at global scale. The company serves over 700 MedTech innovators, accelerating more than 1,000 programmes through 15 international hubs. Whether innovation begins with a sketch, clinical research underway, or regulatory hurdles mid-flight, Veranex meets clients where they are, optimising every decision to produce life-changing patient benefits.


1300
Team Members
2021
Founded
Contract Research
Sector
Hybrid
Work Environment
A world where MedTech innovation reaches patients faster through unified expertise, eliminating the fragmentation that delays breakthroughs and limits global health impact
Veranex exists to accelerate life-improving medical device and diagnostic innovation by uniting design, preclinical, clinical, regulatory, and market access expertise under one integrated Innovation CRO